Assessment of utility of lycopene, selenium, and Vitamin e in management of oral leukoplakia

  • Abhigyan Manas
  • , C. H. Venkateswararao
  • , Shivali Vaid*
  • , Vidhi Dhakray Khanna
  • , M. Muhaseena
  • , Sadaf Alvi
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Objectives: To assess the utility of lycopene, selenium, and vitamin E in the management of leukoplakia. Materials and Methods: In this cross-sectional observational prospective study, 52 patients of oral leukoplakia were divided into 2 groups. Group I patients were prescribed 6 mg of lycopene, 400 I.U. of vitamin E, and 200 μg of selenium twice a day. Group II patients were prescribed a placebo capsule. The clinical improvement was recorded in both groups. Results: The mean pretreatment size of lesion in group I was 9.24 cm 2 and in group II was 8.52 cm 2. Post treatment size was 1.52 cm 2 in group I and 6.28 cm 2 in group II. There was a significant reduction in the size of lesion in group I compared to group II (P < 0.05). Conclusion: The treatment with a combination of lycopene, selenium, and vitamin E is useful and effective in managing the cases of oral leukoplakia.

Original languageEnglish
Pages (from-to)S233-S235
JournalJournal of Pharmacy and Bioallied Sciences
Volume14
Issue number5
DOIs
StatePublished - Jul 2022

Keywords

  • Lycopene
  • oral leukoplakia
  • selenium
  • vitamin E

Fingerprint

Dive into the research topics of 'Assessment of utility of lycopene, selenium, and Vitamin e in management of oral leukoplakia'. Together they form a unique fingerprint.

Cite this